Your browser doesn't support javascript.
loading
Obesity, Adipokines, and Chronic and Persistent Pain in Rheumatoid Arthritis.
Baker, Joshua F; Wipfler, Kristin; Olave, Marianna; Pedro, Sofia; Katz, Patricia; Michaud, Kaleb.
Affiliation
  • Baker JF; Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • Wipfler K; Forward, The National Databank for Rheumatic Diseases, Wichita, Kansas.
  • Olave M; Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
  • Pedro S; Forward, The National Databank for Rheumatic Diseases, Wichita, Kansas.
  • Katz P; School of Medicine, University of California San Francisco, San Francisco, California.
  • Michaud K; Forward, The National Databank for Rheumatic Diseases, Wichita, Kansas; Medicine Service, VA Nebraska-Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, Nebraska.
J Pain ; 24(10): 1813-1819, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37207978
ABSTRACT
We aimed to determine whether adipokines are associated with pain and polysymptomatic distress in patients with rheumatoid arthritis (RA) over time in a large patient registry. The cohort study was conducted in a subset of Forward; a patient-based multi-disease, multipurpose rheumatic disease registry with patients enrolled from community-based rheumatology practices across the U.S. Adipokines (adiponectin, leptin, and fibroblast growth factor[FGF]-21) were measured on stored serum as part of a multi-analyte panel. Body mass index (BMI), pain, polysymptomatic distress, and other patient-reported outcomes (PROs) were reported on biannual questionnaires. Linear regression was used to evaluate independent associations between BMI, adipokines, and PROs. Cox proportional hazards models evaluated independent associations between adipokines and clinically meaningful changes in pain over time (change in numerical rating>1.1 [range 0-10], sustained over 1 year). Among 645 patients included in these analyses, there were significant differences in RA characteristics, comorbidity, PROs, and adipokines across obesity categories. Of note, severely obese patients were more likely to experience greater pain, polysymptomatic distress, and fatigue. Patients with higher FGF-21 levels had higher pain and polysymptomatic stress at baseline, were more likely to use opioids, and were more likely to have sustained worsening pain over time [HR (per 1 SD) (95% CI) 1.22 (1.02,1.46) P = .03] independent of BMI. Obesity and elevated levels of FGF-21 are associated with pain and polysymptomatic distress in RA. Elevated FGF-21 levels may help identify those at risk of worsening pain trajectories over time, independent of BMI. PERSPECTIVE This study characterizes the relationship between severe obesity and pain and polysymptomatic distress in patients with rheumatoid arthritis and demonstrates that the adipocytokine fibroblast growth factor-21 is independently associated with pain and predicts a worsening trajectory over time. Further mechanistic studies are needed.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: J Pain Journal subject: NEUROLOGIA / PSICOFISIOLOGIA Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: J Pain Journal subject: NEUROLOGIA / PSICOFISIOLOGIA Year: 2023 Document type: Article
...